SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission
Study Number: 

PH 264714

Phase: 
Early Phase
Trial categories: 
Leukemia
Acute Myeloid Leukemia (AML)
Early Phase Clinical Trial
Principal Investigator: